Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/1999
07/13/1999CA2179301C Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
07/13/1999CA2000153C Antidote
07/13/1999CA1340650C Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
07/13/1999CA1340649C Purified follicle stimulating hormone
07/13/1999CA1340646C Cyclic anticoagulant peptides
07/13/1999CA1340641C Recombinant lymphotoxin
07/08/1999WO1999034215A1 EXPRESSION AND REFOLDING OF TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (r56) OF ORIENTIA TSUTSUGAMUSHI AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES
07/08/1999WO1999034019A1 Stealth virus nucleic acids and related methods
07/08/1999WO1999034017A1 Reagents and methods useful for detecting diseases of the breast
07/08/1999WO1999034006A2 A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes
07/08/1999WO1999034005A1 Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant
07/08/1999WO1999034004A2 Metastatic breast and colon cancer regulated genes
07/08/1999WO1999033993A1 Promoter from ashbya gossypii
07/08/1999WO1999033992A1 Murine intracisternal a particle constitutive transport elements and uses thereof
07/08/1999WO1999033991A2 TOXINS ACTIVE AGAINST $i(OSTRINIA NUBILALIS)
07/08/1999WO1999033990A1 HUMAN CXC CHEMOKINE (Tim-1)
07/08/1999WO1999033989A2 Rantes mutants and therapeutic applications thereof
07/08/1999WO1999033988A1 A process for preparing human proinsulin
07/08/1999WO1999033987A1 Cloning of a high growth gene
07/08/1999WO1999033986A1 MAMMALIAN ENHANCER OF POLYCOMB (epc) ACTS AS A TUMOR SUPPRESSOR
07/08/1999WO1999033985A2 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION
07/08/1999WO1999033984A1 V197 dna and polypeptides
07/08/1999WO1999033983A1 V201 dna and polypeptides
07/08/1999WO1999033982A2 Human genes and gene expression products i
07/08/1999WO1999033981A2 Human signal peptide-containing proteins
07/08/1999WO1999033980A2 Members of tnf and tnfr families
07/08/1999WO1999033979A2 Bone marrow secreted proteins and polynucleotides
07/08/1999WO1999033978A1 Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins
07/08/1999WO1999033977A1 Tumor antigen protein, gene thereof, and utilization thereof
07/08/1999WO1999033976A1 Polypeptide, their production and use
07/08/1999WO1999033975A1 Heat shock transcription factor-binding protein
07/08/1999WO1999033974A1 Serine proteinase inhibitors
07/08/1999WO1999033973A2 Cloned octapamine-receptor-producing cells
07/08/1999WO1999033972A1 Mammalian edg-5 receptor homologs
07/08/1999WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors
07/08/1999WO1999033965A1 Bifunctional molecules
07/08/1999WO1999033963A1 Metastatic cancer regulated gene
07/08/1999WO1999033961A1 Novel kinase
07/08/1999WO1999033903A1 Products resulting from the association of elastin derivatives with polymers and/or elastin and their biological applications
07/08/1999WO1999033877A1 V196 dna and polypeptides
07/08/1999WO1999033876A1 Novel seven-pass transmembrane receptor protein
07/08/1999WO1999033875A1 Compounds and methods for modulating synaptic stability
07/08/1999WO1999033874A1 Troponin ci complexes
07/08/1999WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
07/08/1999WO1999033872A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids
07/08/1999WO1999033871A2 Essential bacterial genes and their use
07/08/1999WO1999033870A2 Human regulatory proteins
07/08/1999WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
07/08/1999WO1999033868A2 Human papillomavirus vaccine
07/08/1999WO1999033867A2 Modified nucleic acid analogues
07/08/1999WO1999033866A2 Antivirally active oligopeptide isolated from royal jelly
07/08/1999WO1999033860A1 Method for binding albumin and means to be used in the method
07/08/1999WO1999033854A1 Mammalian circadian regulator m-rigui2 (m-per2)
07/08/1999WO1999033488A2 Adjuvanted vaccine formulation
07/08/1999WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
07/08/1999WO1999033482A1 Uses of alpha-conotoxin peptides
07/08/1999WO1999033346A1 Anti-retroviral immunogens, preparation and use
07/08/1999WO1999021994A3 Human vesicle membrane protein-like proteins
07/08/1999WO1999021976A3 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
07/08/1999WO1999021887A3 Method for the production of human blood cytokines
07/08/1999WO1999020760A3 Herg family potassium ion channel genes and protein
07/08/1999WO1999019482A3 Vesicle transport associated proteins
07/08/1999WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
07/08/1999WO1999016406A3 Therapeutic method
07/08/1999WO1999015662A9 Telomere repeat binding factors and diagnostic and therapeutic use thereof
07/08/1999WO1999014357A9 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
07/08/1999WO1999014231A3 Bifidus stimulating peptides and its uses
07/08/1999WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
07/08/1999WO1999009057A3 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
07/08/1999WO1999004265A9 Cancer associated nucleic acids and polypeptides
07/08/1999WO1999002676A3 Mutants of gef proteins
07/08/1999DE19757932A1 Oligopeptide Oligopeptides
07/08/1999DE19749073C1 New protein, LUS-I, and related nucleic acid, antibodies, inhibitors and transgenic animals
07/08/1999CA2316811A1 Anti-retroviral immunogens, preparation and use
07/08/1999CA2316766A1 Method for binding albumin and means to be used in the method
07/08/1999CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors
07/08/1999CA2316403A1 Mammalian edg-5 receptor homologs
07/08/1999CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
07/08/1999CA2316396A1 Tumor antigen protein, gene thereof, and utilization thereof
07/08/1999CA2316283A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein
07/08/1999CA2316079A1 Human regulatory proteins
07/08/1999CA2316017A1 Reagents and methods useful for detecting diseases of the breast
07/08/1999CA2316016A1 V197 dna and polypeptides
07/08/1999CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
07/08/1999CA2315944A1 Bifunctional molecules
07/08/1999CA2315879A1 V201 dna and polypeptides
07/08/1999CA2315750A1 A process for preparing human proinsulin
07/08/1999CA2315702A1 V196 dna and polypeptides
07/08/1999CA2315617A1 Human signal peptide-containing proteins
07/08/1999CA2315534A1 Promoter from ashbya gossypii
07/08/1999CA2315276A1 Human papillomavirus vaccine
07/08/1999CA2315252A1 Essential bacterial genes and their use
07/08/1999CA2315106A1 Toxins active against ostrinia nubilalis
07/08/1999CA2313246A1 Polypeptide, their production and use
07/08/1999CA2312733A1 Troponin ci complexes
07/08/1999CA2282858A1 Stealth virus nucleic acids and related methods
07/07/1999EP0927761A2 Purinebiosynthesis genes from Ashbya possypii and use for the microbial Riboflavinsynthesis
07/07/1999EP0927760A2 Immunreactive parts of the glycoproteins gpII from Varicell-Zoster-Virus
07/07/1999EP0927759A2 Immunoreactive protein VP26 of Varicella Zoster Virus (VZV) and its diagnostic use
07/07/1999EP0927758A2 Recombinant antibodies specific for TNF-Alpha